Strip of 10 Units
Old MRP ₹70.07
MRP ₹65.69
₹52.55
₹6.57/Units
Use current location
Login to view saved addresses
100% genuine medicines
Safe & secure payments
15 days Easy returns
Prescription required for this medicine
Store Between 10°C to 25°C
CompositionGlitaris 15 Tablet 10 is used to treat type 2 diabetes mellitus and belongs to the thiazolidinedione class. It contains pioglitazone, which works primarily by improving the body’s sensitivity to insulin and decreasing glucose production by the liver. This mechanism helps restore glucose regulation, preventing or delaying severe complications of diabetes, such as kidney damage and blindness.
Glitaris 15 Tablet 10 is used to manage type 2 diabetes mellitus and improve glycemic control in patients. It helps restore insulin sensitivity, prevent kidney damage, and reduce the risk of diabetic complications like nerve damage, heart attacks, and stroke. It also helps with preventing sexual dysfunction caused by diabetes.
Here is how you should take Glitaris 15 Tablet 10:
Swallow the tablet whole with a glass of water.
It can be taken with or without food, but try to take it at the same time each day.
Do not crush or chew the tablet.
Do not suddenly stop taking this medicine without consulting your doctor.
Glitaris 15 Tablet 10 is taken orally.
Glitaris 15 Tablet 10 may cause upper respiratory tract infection, headache, sinusitis, myalgia (muscle pain), tooth disorder, aggravated diabetes, and pharyngitis (sore throat).
Most side effects are temporary and generally harmless, which resolves on discontinuing the use of Glitaris 15 Tablet 10. However, if you experience any serious side effects or worsening of any of the symptoms, please consult your doctor.
Here are some general guidelines for managing common side effects:
Headache: If headache occurs after taking this medicine, try taking it at bedtime.
Glitaris 15 Tablet 10 contains pioglitazone (15 mg), which acts on your body in the following ways:
Activates PPAR-γ nuclear receptors: Pioglitazone is a selective agonist of peroxisome proliferator-activated receptor-gamma (PPAR-γ). By activating these receptors, it influences the functioning of genes responsible for managing glucose production, transport and usage.
Reduces insulin resistance: This action of pioglitazone reduces insulin resistance in the liver and peripheral tissues. By doing so, it enhances insulin-dependent glucose disposal and decreases hepatic glucose output – processes vital for controlling blood glucose levels.
If you are pregnant, it is best to consult your doctor before taking Glitaris 15 Tablet 10. This medicine should only be used during pregnancy if the potential benefit outweighs the potential risk to the foetus.
Glitaris 15 Tablet 10 may be excreted in breast milk. Therefore, caution is advised while breastfeeding. Consult your doctor before starting this medicine.
It is advisable to limit alcohol consumption while managing your type 2 diabetes with this medicine.
If you have liver problems, discuss them with your doctor before starting Glitaris 15 Tablet 10. Regular liver enzyme monitoring is recommended, as this medicine can affect liver function.
Caution is advised before taking Glitaris 15 Tablet 10 if you have a history of kidney problems. It's a good idea to consult your doctor before starting this medicine.
Glitaris 15 Tablet 10 do not usually affect your ability to drive or operate machinery. However, if you feel unwell or experience any side effects, avoid these activities and discuss with your doctor.
Do not take Glitaris 15 Tablet 10 if you are allergic to pioglitazone or any other ingredients in the tablet. Discuss any known allergies with your doctor before starting this medication.
Glitaris 15 Tablet 10 is not recommended for use in children under 18 years of age. Always consult your doctor before giving any medicine to a child.
Older patients may need closer monitoring and dose adjustments when taking Glitaris 15 Tablet 10 due to possible age-related changes in kidney or liver function. It is advisable for older patients above 70 years of age to start this medicine under the supervision of a doctor.
Glitaris 15 Tablet 10 Interacts with the following medicines:
CYP2C8 inhibitors: Medicines like gemfibrozil may increase the concentration of pioglitazone in your body, possibly leading to higher chances of side effects.
CYP2C8 inducers: Medicines such as rifampin can decrease the concentration of pioglitazone, which may lower its effectiveness.
There are no known food interactions with Glitaris 15 Tablet 10.
Glitaris 15 Tablet 10 Interacts with the following diseases:
Heart disease: Pioglitazone can cause fluid retention, which could worsen heart failure in people with pre-existing heart conditions.
Liver disease: People having liver problems should exercise caution while taking Glitaris 15 Tablet 10 as it may escalate their condition.
Bladder cancer: This medicine is not recommended for individuals with active bladder cancer or a history of this disease due to potential risks.
Your daily dose of Glitaris 15 Tablet 10 should be as your doctor directs. However, the dosage can vary depending on individual factors such as the severity of your condition and your response to the medicine. Therefore, always adhere to your prescribed dosage and don't exceed it without first consulting with your doctor.
In case of an overdose, you might experience side effects like headaches, fluid retention, or muscle pain more intensely. If this happens, inform your doctor promptly.
If you've missed a dose of Glitaris 15 Tablet 10, take it as soon as you remember. However, if it's nearly time for your next dose, skip the one you missed and continue with your regular schedule. Never adjust your dosage without consulting your doctor.
Store Glitaris 15 Tablet 10 at room temperature, ideally below 30°C.
The storage area should be dry and away from direct sunlight and heat.
Keep the medicine in its original, tightly closed container to protect it from moisture.
Always ensure it's out of reach of children
As Glitaris 15 Tablet 10 is used to manage type 2 diabetes, you should follow a balanced diet that's low in sugar. This helps control blood glucose levels and boosts the medicine's efficacy.
Regular physical activity is crucial. Light exercises like walking can enhance your body's sensitivity to insulin, which aids in keeping your blood sugar levels stable. Always consult your doctor before starting any new exercise regimen.
| Dosage Forms Available | Tablet |
| Habit Forming | No |
| Ailment | Type 2 Diabetes Mellitus |
| Drug Category | PPAR-γ (Peroxisome Proliferator-Activated Receptor Gamma) Agonist |
| Therapeutic Category | Antidiabetic |
Glitaris 15 Tablet 10 is taken to manage adult type 2 diabetes by improving blood sugar control. It's generally used alongside a healthy diet and regular exercise.
This medication contains pioglitazone, which reduces insulin resistance in the body. This process helps to regulate your blood sugar levels effectively.
Yes, but some medicines, such as gemfibrozil and rifampin, can interact with it, altering its effectiveness. Always consult your doctor before starting any new medication.
Monitor your blood sugar levels regularly, and report any unusual symptoms, such as vision changes or swelling, to your doctor immediately.
Common side effects include headache and muscle pain. Rare but serious side effects include heart failure and liver problems. Consult your doctor if they persist or worsen.
The usage of this medicine during pregnancy should be discussed with your doctor, as the benefits must outweigh the potential risks to the unborn baby.
Store at room temperature below 30°C in a tightly closed container, away from light and moisture. Keep out of reach of children.
Check out Editorial Policy
Pioglitazone: uses, interactions, mechanism of action | DrugBank Online. (n.d.). DrugBank. https://go.drugbank.com/drugs/DB01132
PubChem. (n.d.-k). Pioglitazone. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/4829
Pioglitazone: MedlinePlus drug information. (n.d.). https://medlineplus.gov/druginfo/meds/a699016.html
DailyMed - PIOGLITAZONE tablet. (n.d.). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8f2d7000-37ca-4e09-98ec-07d1c0354cb3
Research, C. F. D. E. A. (2016, December 7). FDA Drug Safety Communication: Updated drug labels for pioglitazone-containing medicines. U.S. Food And Drug Administration. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-updated-drug-labels-pioglitazone-containing-medicines
We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.
62% CHEAPER
21781 users bought this instead
...View more
...View more
...View more
Company
About UsHealth ArticleHealth StoriesHealth LibraryDiseases & Health ConditionsAyurvedaUnderstanding Generic MedicinesAll MedicinesAll BrandsNeed HelpFAQSecuritySavings CalculatorSubscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v4.22.3
2026 - Truemeds | All rights reserved. Our content is for informational purposes only. See additional information.
Our Payment Partners
